SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Firenze who wrote (1384)8/6/1999 11:51:00 AM
From: Doug Bean  Read Replies (1) of 1837
 
For what its worth , DRMD did say in the CC that they were already approved on Formulary in 75% of managed care outlets.

I spoke with my Doctor yesterday and he said that they were very wise in going to doctors first and that he would have been offended if they had gone to the public first and had the public coming to them asking about a product where the physicians had not been fully educated ahead of time.
At any rate time is what is required and not everyone is going to be a Cenestin convert.. That there is as much current interest as the CC indicated is wonderful and the rest will have to come in time.
I am looking at one year from now as my time line to see if Cenestin has made significant inroads to the point that later it is going to fly really high. I hope to see all kinds of good thing prior to that and would love to see the price move to the high teens to low 20s right after the first of the year,,, but thats just what i want not what may happen.
CRDoug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News